Advanced search
Publication Cover
Expert Opinion on Drug Safety Volume 15, 2016 - Issue 10
Submit an article Journal homepage
556
Views
9
CrossRef citations to date
0
Altmetric
Review

The safety of pharmacologic options for the treatment of persons with hemophilia

Massimo FranchiniDepartment of Transfusion Medicine and Hematology, Carlo Poma Hospital, Mantova, ItalyView further author information
&
Pier Mannuccio MannucciAngelo Bianchi Bonomi Hemophilia and Thrombosis Center, Fondazione IRCCS Ca’ Granda-Ospedale Maggiore Policlinico and University of Milan, Milan, ItalyCorrespondence[email protected]
View further author information
Pages 1391-1400 | Received 12 May 2016, Accepted 29 Jun 2016, Published online: 18 Jul 2016

Citations (9)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Yvonne Brennan, Jennifer Curnow & Emmanuel J. Favaloro. (2018) Trenonacog alfa for prophylaxis, on-demand and perioperative management of hemophilia B. Expert Opinion on Biological Therapy 18:1, pages 95-100.
Read now
Massimo Franchini & Pier Mannuccio Mannucci. (2017) Efficacy and safety of a recombinant factor VIII produced from a human cell line (simoctocog alfa). Expert Opinion on Drug Safety 16:3, pages 405-410.
Read now

Articles from other publishers (7)

Massimo Franchini & Pier Mannuccio Mannucci. (2022) The More Recent History of Hemophilia Treatment. Seminars in Thrombosis and Hemostasis 48:08, pages 904-910.
Crossref
Hassan Mansouritorghabeh & Seyedeh T. Mohades. (2020) Is the Detection of Factor IX Inhibitors in Hemophilia B Orphan than Factor VIII Inhibitors in Hemophilia A? A Concise, Systematic Review. Cardiovascular & Hematological Disorders-Drug Targets 20:3, pages 185-190.
Crossref
Mario Schiavoni, Mariasanta Napolitano, Gaetano Giuffrida, Antonella Coluccia, Sergio Siragusa, Valeria Calafiore, Giuseppe Lassandro & Paola Giordano. (2019) Status of Recombinant Factor VIII Concentrate Treatment for Hemophilia A in Italy: Characteristics and Clinical Benefits. Frontiers in Medicine 6.
Crossref
Charles Nakar & Amy Shapiro. (2019) Hemophilia A with inhibitor: Immune tolerance induction (ITI) in the mirror of time. Transfusion and Apheresis Science 58:5, pages 578-589.
Crossref
S. W. Pipe. (2018) Bioengineered molecules for the management of haemophilia: Promise and remaining challenges. Haemophilia 24, pages 68-75.
Crossref
Massimo Franchini & Pier Mannuccio Mannucci. (2017) Management of Hemophilia in Older Patients. Drugs & Aging 34:12, pages 881-889.
Crossref
Massimo Franchini & Giuseppe Lippi. (2016) Prevention of inhibitor development in hemophilia A in 2016. A glimpse into the future?. Thrombosis Research 148, pages 96-100.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.